Page last updated: 2024-08-24

milnacipran and Alzheimer Disease

milnacipran has been researched along with Alzheimer Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biswas, D; Hameed, N; Khan, M; Rizvi, SM; Shaikh, S; Shakil, S	1
Asada, T; Hatanaka, K; Mizukami, K; Sato, S; Tanaka, Y	1
Asada, T; Mizukami, K; Tanaka, Y	1

Trials

1 trial(s) available for milnacipran and Alzheimer Disease

Article	Year
Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	2006

Article

Year

Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease.

Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7

Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome

2006

Other Studies

2 other study(ies) available for milnacipran and Alzheimer Disease

Article	Year
Fetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1. CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:8 Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Antidepressive Agents; Aspartic Acid Endopeptidases; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Molecular Docking Simulation; Serotonin Plasma Membrane Transport Proteins	2014
Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Nootropic Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2009

Article

Year

Fetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1.

CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:8

Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Antidepressive Agents; Aspartic Acid Endopeptidases; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Molecular Docking Simulation; Serotonin Plasma Membrane Transport Proteins

2014

Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease.

Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2

Topics: Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Nootropic Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors

2009